Trial Information
CONVENTIONAL AND EXPERIMENTAL CHEMOTHERAPY WITH ALLOGENEIC TRANSPLANT IN YOUNG PATIENTS WITH ACUTE MYELOID LEUKAEMIA
Inclusion Criteria
Patients with acute myeloid leukemia (<=66 years), treated with conventional and
experimental chemotherapy following allogeneic transplantation. THis patients have been
enrolled from 2000 to 2011 at the Division of Hematology, Molinette University Hospital.
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
Overall survival
Outcome Time Frame:
1 year
Safety Issue:
Yes
Principal Investigator
Benedetto Bruno, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Divisione di Ematologia-Città della Salute e della Scienza di Torino
Authority:
Italy: Ministry of Health
Study ID:
AML-TO-2012
NCT ID:
NCT01785953
Start Date:
February 2013
Completion Date:
February 2014
Related Keywords:
- Acute Myeloid Leukemia
- Leukemia
- Leukemia, Myeloid, Acute
- Leukemia, Myeloid